Research graph
References from Establishment of an Animal Model of Type 2 Cardiorenal Syndrome. Local targets link to admitted publications; unresolved targets remain external evidence.
Burden of Heart Failure and Underlying Causes in 195 Countries and Territories From 1990 to 2017
10.1093/eurjpc/zwaa147 · 2021 · External reference
Incidence and Epidemiology of New Onset Heart Failure With Preserved vs. Reduced Ejection Fraction in a Community‐Based Cohort: 11‐Year Follow‐Up of PREVEND
10.1093/eurheartj/eht066 · 2013 · External reference
Global Public Health Burden of Heart Failure
10.15420/cfr.2016:25:2 · 2017 · External reference
Cardiovascular Disease and Subsequent Kidney Disease
10.1001/archinte.167.11.1130 · 2007 · External reference
Cardiorenal Nexus: A Review With Focus on Combined Chronic Heart and Kidney Failure, and Insights From Recent Clinical Trials
10.1161/jaha.121.024139 · 2022 · External reference
eGFR Slope as Predictor of Mortality in Heart Failure Patients
10.1002/ehf2.15128 · 2025 · External reference
Consensus Document on Palliative Care in Cardiorenal Patients
10.3389/fcvm.2023.1225823 · 2023 · External reference
2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
10.1093/eurheartj/ehab368 · 2021 · External reference
European Society of Cardiology Heart Failure Long‐Term Registry (ESC‐HF LT):1‐Year Follow‐Up Outcomes and Differences Across Regions
10.1002/ejhf.566 · 2016 · External reference
Blood Pressure and Incidence of Twelve Cardiovascular Diseases: Lifetime Risks, Healthy Life‐Years Lost, Andage‐Specific Associations in 1.25 Million People
10.1016/s0140-6736(14)60685-1 · 2014 · External reference
Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension
10.1161/cir.0000000000000207 · 2015 · External reference
Depression Risk in Patients With Coronary Heart Disease in Germany
10.4330/wjc.v8.i9.547 · 2016 · External reference
Qiangxin Bushen Decoction Attenuates Cardiorenal Syndrome Type II via AMPK/FOXO1‐Mediated Ferroptosis Pathway: A Multi‐Omics and Experimental Study
10.1016/j.phymed.2025.157247 · 2025 · External reference
Excessive Fibroblast Growth Factor 23 Promotes Renal Fibrosis in Mice With Type 2 Cardiorenal Syndrome
10.18632/aging.202448 · 2021 · External reference
Wnt/β‐Catenin Signaling Mediates Both Heart and Kidney Injury in Type 2 Cardiorenal Syndrome
10.1016/j.kint.2018.11.021 · 2019 · External reference
Mildly Increased Renin Expression in the Absence of Kidney Injury in the Murine Transverse Aortic Constriction Model
10.3389/fphar.2021.614656 · 2021 · External reference
A Novel and Efficient Model of Coronary Artery Ligation and Myocardial Infarction in the Mouse
10.1161/circresaha.110.223925 · 2010 · External reference
Modified Technique for Coronary Artery Ligation in Mice
2013 · External reference
Minimally Invasive Transverse Aortic Constriction in Mice
2017 · External reference
The Cardiorenal Syndrome in Heart Failure
10.1016/j.ccl.2021.12.010 · 2022 · External reference
SGLT2 Inhibitors in the Treatment of Type 2 Cardiorenal Syndrome: Focus on Renal Tubules
10.3389/fneph.2022.1109321 · 2023 · External reference
The Role of Inflammation in the Cardio‐Renal Syndrome: A Focus on Cytokines and Inflammatory Mediators
10.1016/j.semnephrol.2011.11.010 · 2012 · External reference
Sirtuins and Resveratrol in Cardiorenal Diseases: A Narrative Review of Mechanisms and Therapeutic Potential
10.3390/nu17071212 · 2025 · External reference
Fibrosis, the Bad Actor in Cardiorenal Syndromes: Mechanisms Involved
10.3390/cells10071824 · 2021 · External reference
Cardiorenal Syndrome Revisited
10.1161/circulationaha.117.028814 · 2018 · External reference
Animal Models of Cardiorenal Syndrome: A Review
10.1007/s10741-011-9279-6 · 2012 · External reference
Target Organ Cross Talk in Cardiorenal Syndrome: Animal Models
10.1152/ajprenal.00392.2012 · 2012 · External reference
Heart‐Kidney Interactions: Mechanistic Insights From Animal Models
10.1152/ajprenal.00624.2017 · 2019 · External reference
The Role of Echocardiography in the Diagnosis and Management of Heart Failure
10.1023/a:1023001104207 · 2003 · External reference
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
10.1016/j.cardfail.2022.02.010 · 2022 · External reference
Biomarkers for the Diagnosis and Management of Heart Failure
10.1007/s10741-021-10105-w · 2022 · External reference
Creatinine: From Physiology to Clinical Application
10.1016/j.ejim.2019.10.025 · 2020 · External reference
CNN‐Assisted SERS Enables Ultra‐Sensitive and Simultaneous Detection of Scr and BUN for Rapid Kidney Function Assessment
10.1039/d2ay01573k · 2023 · External reference
Predictor and Prognostic Modeling in Cardiorenal Syndrome Type 2: A Retrospective Study of Multicenter
10.1080/17520363.2025.2520738 · 2025 · External reference
Pathophysiology of Cardiorenal Syndrome Type 2 in Stable Chronic Heart Failure: Workgroup Statements From the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI)
10.1159/000349968 · 2013 · External reference
Estimating Glomerular Filtration Rate From Serum Creatinine and Cystatin C
10.1056/nejmoa1114248 · 2012 · External reference
Plasma Kidney Injury Molecule 1 in CKD: Findings From the Boston Kidney Biopsy Cohort and CRIC Studies
10.1053/j.ajkd.2021.05.013 · 2022 · External reference
Cardiorenal Syndrome and Inflammation: A Forgotten Frontier Resolved by Sorbents?
2024 · External reference
Interleukin‐6, Tumor Necrosis Factor‐α, and High‐Sensitivity C‐Reactive Protein for Optimal Immunometabolic Profiling of the Lifestyle‐Related Cardiorenal Risk
10.1515/dx-2023-0159 · 2024 · External reference
Gualou Xiebai Decoction Ameliorates Cardiorenal Syndrome Type II by Regulation of PI3K/AKT/NF‐κB Signalling Pathway
10.1016/j.phymed.2023.155172 · 2024 · External reference
Depleting Profibrotic Macrophages Using Bioactivated In Vivo Assembly Peptides Ameliorates Kidney Fibrosis
10.1038/s41423-024-01190-6 · 2024 · External reference
Pathophysiology of the Cardio‐Renal Syndromes Types 1‐5: An Uptodate
10.1016/j.ihj.2017.01.005 · 2017 · External reference
Cardiorenal Syndrome: Molecular Pathways Linking Cardiovascular Dysfunction and Chronic Kidney Disease Progression
10.3390/ijms26157440 · 2025 · External reference
